Galileo and Fujikura in distribution agreement:
This article was originally published in Clinica
Executive Summary
Galileo Electro-Optics is to distribute Fujikura's high pixel count optical fibre for endoscopic medical devices in the US and Puerto Rico. The product will be marketed under the name Ultra-Vue and will be available in 10,000, 15,000 and 30,000 pixel count formats. Fujikura, which is headquartered in Tokyo, Japan, manufactures fibre-optic and electronic products for a broad range of applications. US company Galileo manufactures and markets fibre-optics and electro-optic components and systems for transmitting, sensing or intensifying light or images.
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.